U.S. Women’s Health Devices Market: USD 65.89B by 2035

Market Outlook

By 2035, the U.S. Women’s Health Devices Market is expected to reach approximately USD 65.89 billion, growing at a CAGR of 9.64% during the forecast period 2026–2035. The market was valued at USD 26.25 billion in 2025, with historical analysis from 2021 to 2024. Values in this report are expressed in USD billions.

The U.S. women’s health devices industry is evolving from a collection of discrete obstetric, gynecologic, breast imaging, fertility, and pelvic health products into a connected life-stage care ecosystem. Demand is supported by a female population representing approximately half of the country, more than 3.6 million annual births, over 43 million reported mammography procedures, a large and aging postmenopausal population, and substantial unmet need in infertility, uterine disorders, endometriosis, urinary incontinence, osteoporosis, and maternal risk management. The market therefore combines high-volume screening equipment, procedure-based consumables, capital systems, implantable and disposable devices, point-of-care diagnostics, and consumer-facing connected products.

Market growth is shifting toward technologies that shorten diagnostic pathways and reduce the treatment burden created by delayed detection. In breast health, digital breast tomosynthesis, contrast-enhanced mammography, ultrasound, MRI workflow tools, biopsy systems, specimen imaging, localization devices, and artificial intelligence are being integrated into risk-based screening pathways. In gynecology, hospital and ambulatory buyers are favoring hysteroscopic tissue removal, endometrial ablation, radiofrequency fibroid treatment, minimally invasive laparoscopy, robotic assistance, advanced energy, and office-based visualization. Fertility clinics are investing in incubators, micromanipulation systems, cryostorage, genetic testing workflows, sperm-selection technologies, and automation that can improve laboratory consistency.

The historical market expanded from an estimated USD 17.95 billion in 2021 to USD 23.90 billion in 2024, supported by the normalization of deferred screening, rebound of elective gynecologic procedures, expanding fertility treatment volumes, stronger adoption of three-dimensional mammography, and accelerated uptake of home-use reproductive and lactation devices. In 2025, the market reached USD 26.25 billion as integrated delivery networks renewed women’s imaging fleets, ambulatory gynecology capacity expanded, pelvic health portfolios consolidated, and manufacturers increased the software content of diagnostic and monitoring platforms.

Introduction

According to the U.S. Women’s Health Devices Market Report, the market is shaped by a combination of high screening intensity, a sophisticated specialist network, advanced imaging infrastructure, mature reimbursement channels, and persistent gaps in access and diagnosis. The category includes devices used across breast health, gynecologic surgery, reproductive medicine, contraception, pregnancy and childbirth, pelvic floor dysfunction, menopause-related care, and skeletal health. It also includes the software, disposables, accessories, service contracts, and workflow tools that make these clinical platforms commercially viable.

Women’s health care in the United States is device-intensive because many conditions require repeated imaging, procedure-based diagnosis, longitudinal monitoring, or specialized interventions. Breast cancer screening depends on a national installed base of mammography and tomosynthesis systems. Pregnancy care relies on ultrasound, fetal monitoring, maternal surveillance, labor and delivery equipment, and postpartum hemorrhage management. Infertility treatment depends on a highly controlled laboratory environment, while fibroids, abnormal uterine bleeding, endometriosis, and pelvic organ disorders often require visualization, ablation, resection, implants, energy devices, or robotic surgery.

The market is closely connected to U.S. clinical workflow economics. Hospitals and large physician groups do not evaluate a women’s health device only through acquisition price. They assess whether the platform can improve radiologist productivity, reduce repeat imaging, support same-day diagnosis, increase operating room or procedure-room turnover, shift cases to lower-cost settings, reduce anesthesia use, shorten recovery, strengthen quality reporting, and capture reimbursable service volume. In fertility and maternal care, buyers also consider laboratory consistency, patient throughput, data traceability, staff training burden, and the risk of adverse outcomes.

From 2026 to 2035, the defining strategic theme will be the transition from episodic women’s health intervention to longitudinal, data-enabled care. Manufacturers that connect screening, diagnosis, treatment, monitoring, and patient engagement will be better positioned than suppliers offering isolated products. The strongest commercial platforms will help clinicians identify risk earlier, manage dense or complex diagnostic cases, treat benign gynecologic disease without major surgery, improve pregnancy surveillance, expand access to fertility services, and support pelvic and menopausal health outside traditional hospital settings.

Key Market Drivers: What’s Fueling the U.S. Women’s Health Devices Market Boom?

The first major driver is the scale of unmet clinical need across multiple women-specific conditions. Breast cancer remains one of the most common cancers in the country, with approximately 319,750 new female breast cancer cases expected in 2025. Uterine fibroids affect a substantial share of women by age 50, endometriosis is estimated to affect millions of U.S. women, and urinary incontinence is experienced by roughly half of women at some point. Among women aged 50 and older, osteoporosis affects close to one in five. This burden supports demand for screening equipment, biopsy systems, minimally invasive treatment platforms, pelvic floor devices, bone density systems, and home-based symptom management technologies.

A second driver is the expansion and increasing sophistication of reproductive medicine. National data indicate that 13.4% of U.S. women aged 15–49 have impaired fecundity, while infertility rates are considerably higher among married women with no prior births. In 2022, 435,426 assisted reproductive technology cycles were performed on more than 251,000 patients at 457 reporting U.S. clinics, resulting in more than 98,000 live-born infants. These volumes support recurring demand for IVF incubators, cryogenic storage, micromanipulation systems, embryo assessment tools, aspiration needles, transfer catheters, sperm-processing devices, fertility monitoring products, and laboratory software.

A third driver is the size and complexity of the U.S. maternal care pathway. The country recorded approximately 3.63 million births in 2024, including more than 1.17 million cesarean deliveries. The cesarean rate reached 32.4%, while preterm births remained above 10%. Maternal mortality also remains an important quality and policy concern; 669 women died from maternal causes in 2023, corresponding to a rate of 18.6 deaths per 100,000 live births. These conditions sustain procurement of fetal and maternal monitors, ultrasound systems, wireless surveillance, labor and delivery beds, surgical equipment, postpartum hemorrhage devices, neonatal transition equipment, and remote pregnancy monitoring platforms.

A fourth driver is the migration of appropriate procedures from inpatient operating rooms to hospital outpatient departments, ambulatory surgery centers, and office-based gynecology suites. Hysteroscopy, endometrial ablation, tissue removal, selected fibroid procedures, pelvic floor interventions, breast biopsy, image-guided localization, and fertility procedures can increasingly be performed with shorter recovery and less capital intensity than traditional inpatient surgery. This shift expands the addressable customer base for compact platforms, single-use scopes, procedure kits, portable imaging, office-friendly fluid management, and technologies that reduce the need for general anesthesia.

A fifth driver is hospital capital procurement behavior. Women’s imaging and obstetric service lines are important for patient acquisition because they create long-term relationships with health systems across screening, pregnancy, surgery, oncology, and primary care. Health systems invest in premium platforms when the technology can increase referrals, protect regional market share, recruit specialists, and produce measurable throughput gains. Breast imaging replacement cycles are particularly important because tomosynthesis, artificial intelligence, contrast-enhanced workflows, and density reporting requirements are raising expectations for hardware performance, cybersecurity, interoperability, and enterprise analytics.

A sixth driver is the growth of connected, home-use, and consumer-mediated women’s health technology. Wearable breast pumps, fertility trackers, ovulation tests, connected pelvic floor trainers, remote blood pressure monitoring in pregnancy, mobile ultrasound, menopause monitoring, and digital symptom platforms are broadening the market beyond hospital procurement. Growth is strongest where a product can generate clinically actionable data, integrate into professional workflows, and demonstrate regulatory discipline. Privacy, evidence quality, and data governance are becoming central procurement criteria because reproductive and maternal health information is highly sensitive.

A seventh driver is regulatory and policy attention. Federal mammography rules now require breast density notification, increasing the importance of consistent density assessment, supplemental imaging pathways, patient communication, and radiology workflow tools. Public investment in women’s health research is also encouraging development in historically underfunded areas such as endometriosis, menopause, maternal health, and uterine disease. For manufacturers, the commercial advantage will come from translating regulatory compliance and clinical evidence into a credible value proposition for hospitals, payers, physicians, and patients.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. women’s health devices market is increasingly focused on reducing diagnostic delay, improving procedural efficiency, and supporting more personalized care. The next generation of products is not defined only by better image quality or smaller instruments. Competitive differentiation is moving toward systems that combine hardware, software, consumables, workflow automation, clinical decision support, and longitudinal data. This is particularly important in women’s health, where fragmented care pathways often create repeated visits, delayed diagnosis, and inconsistent handoffs between radiology, obstetrics, gynecology, oncology, primary care, and fertility specialists.

Artificial intelligence in breast imaging is one of the most visible innovation areas. AI-enabled detection, triage, breast density assessment, prior-image comparison, and workflow orchestration are being positioned as productivity tools as well as diagnostic aids. The U.S. mammography network reported more than 43 million annual procedures in early 2025 across nearly 9,000 certified facilities and more than 26,000 accredited units. At that scale, even modest reductions in reading time, recall burden, or worklist imbalance can create meaningful economic value. The new federal density notification framework also increases demand for standardized reporting and risk-based follow-up.

Minimally invasive gynecologic treatment is another defining innovation cycle. Transcervical radiofrequency ablation, hysteroscopic tissue removal, global endometrial ablation, advanced bipolar energy, contained tissue extraction, and image-guided uterine procedures are creating alternatives to hysterectomy for selected patients. The commercial opportunity is significant because fibroids and abnormal uterine bleeding affect large patient populations, yet many women delay treatment because of concerns about recovery, fertility, or major surgery. Platforms that preserve the uterus, shorten procedural time, and fit outpatient economics are likely to gain share.

Fertility technology is advancing through laboratory automation, environmental control, noninvasive embryo assessment, time-lapse imaging, cryostorage monitoring, electronic witnessing, and improved gamete-handling consumables. Fertility clinics operate under a high-consequence workflow in which small variations in temperature, gas concentration, sample identity, and handling can affect outcomes. Device companies are therefore competing on process control and traceability as much as on individual instruments. Technologies that improve reproducibility without creating excessive laboratory complexity will be favored by multi-site fertility networks.

Maternal and fetal monitoring is moving toward wireless, continuous, and risk-stratified surveillance. Hospitals are evaluating cable-free fetal monitoring, maternal hemodynamic tracking, portable and handheld ultrasound, AI-assisted fetal biometry, remote blood pressure monitoring, and integrated early-warning dashboards. The objective is to identify deterioration sooner while reducing alarm burden and nursing workload. In outpatient and rural settings, portable imaging and remote monitoring can extend specialist reach, but adoption will depend on validated accuracy, reliable connectivity, and clear clinical escalation protocols.

Pelvic health innovation is broadening beyond conventional surgical repair. Sacral neuromodulation, tibial nerve stimulation, bulking agents, pessary innovation, biofeedback, connected pelvic floor rehabilitation, and office-based diagnostic tools are expanding treatment options for urinary and bowel dysfunction. The category is attractive because prevalence is high while treatment penetration remains low. Manufacturers that simplify patient selection, programming, follow-up, and reimbursement support can unlock demand that is currently constrained by underdiagnosis and fragmented referral pathways.

Across all categories, evidence generation is becoming more rigorous. U.S. buyers increasingly expect randomized trials, prospective registries, real-world performance, health economic models, workflow studies, and subgroup analyses that reflect diverse patient populations. The strongest products will demonstrate not only technical performance but also fewer repeat procedures, reduced operating time, lower downstream utilization, faster return to normal activity, more equitable access, and improved patient-reported outcomes.

Segmentation Insights

The U.S. Women’s Health Devices Market is segmented on the basis of product category, application, technology type, end user, and life stage.

By Product Category

Breast health imaging, biopsy, and intervention devices. This is the largest product category, representing an estimated USD 7.48 billion in 2025. It includes digital mammography, digital breast tomosynthesis, breast ultrasound, MRI coils and workflow tools, contrast-enhanced mammography, computer-aided detection, AI software, stereotactic biopsy systems, needles, localization products, specimen radiography, and surgical guidance technologies. Growth is supported by the large national screening base, aging equipment, density notification, and demand for more efficient diagnostic pathways. Capital replacement cycles are long, but software upgrades, service contracts, biopsy consumables, and localization products provide recurring revenue.
Gynecological surgical and therapeutic devices. This category includes hysteroscopes, resectoscopes, tissue removal systems, endometrial ablation platforms, fibroid ablation systems, uterine manipulators, electrosurgical devices, fluid management systems, laparoscopic instruments, robotic accessories, morcellation-related containment products, and gynecologic oncology tools. It is among the most strategically attractive segments because benign uterine disease generates substantial procedure volume and because minimally invasive alternatives can shift cases from inpatient surgery to outpatient settings. Differentiation depends on visualization, speed, tissue access, uterine preservation, and total procedure cost.
Reproductive health, fertility, and contraceptive devices. The segment includes IVF incubators, micromanipulators, cryostorage systems, aspiration needles, embryo transfer catheters, cultureware, sperm-processing devices, fertility monitors, ovulation testing, intrauterine devices, contraceptive implants, tubal occlusion and sterilization instruments, and electronic laboratory management systems. Fertility devices benefit from rising treatment intensity, delayed childbearing, and clinic consolidation. Contraceptive device demand is influenced by payer coverage, clinical preference, state policy, patient choice, and provider training.
Pregnancy, labor, maternal, and fetal monitoring devices. This segment includes obstetric ultrasound, fetal monitors, maternal vital-sign surveillance, uterine contraction monitoring, labor and delivery beds, vacuum and forceps systems, fetal scalp electrodes, postpartum hemorrhage balloons and control devices, wireless monitoring, and remote pregnancy tools. Revenue is supported by more than 3.6 million annual births and the high-acuity requirements of labor and delivery departments. Growth is shifting toward integrated maternal-fetal monitoring, portable ultrasound, interoperability, and risk-based surveillance.
Pelvic floor and urogynecology devices. The category includes sacral neuromodulation systems, tibial nerve stimulation devices, slings, pessaries, bulking agents, pelvic floor diagnostics, urodynamic systems, biofeedback platforms, vaginal support devices, and connected rehabilitation products. Market penetration remains below the underlying disease burden because many women do not seek care or are not referred to specialists. Consolidation among device manufacturers is increasing commercial scale, while office-based therapy and remote follow-up are expanding access.
Bone health, menopause, lactation, and home-use devices. This category covers DXA bone densitometry, body composition systems, wearable breast pumps, pelvic and vaginal wellness devices with medical claims, menopause monitoring tools, home fertility diagnostics, connected thermometry, and selected remote monitoring equipment. It is smaller than breast imaging or gynecologic surgery but is growing quickly because it links clinical care with direct-to-consumer adoption. The segment’s long-term success will depend on evidence, affordability, reimbursement pathways, and responsible handling of sensitive data.

By Application

Breast cancer screening, diagnosis, and treatment support. This application remains the largest revenue pool because of recurring screening, high procedure volumes, and a sophisticated installed base. Demand is moving beyond standard two-dimensional mammography toward tomosynthesis, AI-assisted interpretation, supplemental ultrasound and MRI, density assessment, image-guided biopsy, lesion localization, and surgical navigation. Providers prioritize technologies that can increase cancer detection while controlling recall rates and radiologist workload.
Uterine, cervical, ovarian, and benign gynecologic disorder management. Applications include abnormal uterine bleeding, fibroids, endometriosis, polyps, cervical disease, adnexal disease, infertility-related anatomy, and gynecologic cancer. Device demand spans diagnostic ultrasound, colposcopy, hysteroscopy, biopsy, ablation, resection, laparoscopy, robotics, advanced energy, and specimen management. Growth is strongest where technology can shorten the interval from diagnosis to treatment and reduce reliance on open surgery.
Fertility, assisted reproduction, and family planning. This application combines clinic-based capital equipment, high-frequency disposable products, laboratory software, and long-duration patient engagement. ART volume creates recurring demand for procedure kits, culture systems, cryogenic supplies, and transfer devices. Family planning adds intrauterine devices, contraceptive implants, sterilization instruments, and home fertility monitoring. Buyers require reliable supply, traceability, and regulatory support because treatment cycles are time-sensitive.
Pregnancy, childbirth, and postpartum care. The application includes routine obstetric imaging, high-risk pregnancy surveillance, intrapartum fetal monitoring, maternal vital-sign tracking, operative delivery, cesarean support, hemorrhage control, and postpartum remote monitoring. The high U.S. cesarean rate and persistent maternal outcome disparities support demand for better risk identification and standardized escalation. Hospitals increasingly favor systems that integrate with electronic records and reduce manual documentation.
Pelvic floor dysfunction, urinary incontinence, and sexual health. This application addresses urinary leakage, overactive bladder, fecal incontinence, pelvic organ prolapse, postpartum pelvic dysfunction, and selected sexual health conditions. The underlying patient pool is large, but treatment is often delayed. Growth depends on expanding awareness, improving referral pathways, and offering less invasive options. Device companies are focusing on neuromodulation, office-based treatment, implant longevity, remote programming, and patient adherence.
Menopause, osteoporosis, and healthy aging. This application includes bone density assessment, fracture-risk evaluation, genitourinary symptom management, body composition, and home monitoring. Nearly one in five U.S. women aged 50 and older has osteoporosis at the femur neck or lumbar spine. Aging demographics will support demand for DXA replacement, compact screening, longitudinal bone health analytics, and devices that can be integrated into menopause and primary care pathways.

By Technology Type

Imaging and image-guided technologies. Digital mammography, tomosynthesis, ultrasound, MRI, DXA, colposcopy, hysteroscopy, optical imaging, and image-guided biopsy form the market’s largest technology base. Imaging platforms influence downstream procedure volume and are often purchased as enterprise systems. Growth is increasingly software-led, with AI, automated measurements, risk stratification, and cloud-based quality analytics extending the value of installed hardware.
Minimally invasive surgical and energy-based technologies. This segment includes hysteroscopic systems, laparoscopy, robotics, radiofrequency ablation, thermal ablation, electrosurgery, ultrasonic energy, fluid management, and image-guided therapy. It is expected to grow faster than conventional open-surgery equipment because hospitals and patients favor shorter recovery and lower episode cost. Vendors compete on procedural simplicity, disposable economics, safety controls, and physician training.
Implantable, disposable, and procedure-based technologies. Intrauterine devices, contraceptive implants, pelvic floor implants, neuromodulation leads and generators, biopsy needles, transfer catheters, retrieval devices, specimen systems, and procedure kits create recurring revenue. This segment benefits from high repeat utilization but is exposed to supply-chain reliability, contracting pressure, and clinician preference. Products with clear clinical differentiation can retain premium pricing despite group purchasing pressure.
Laboratory automation and diagnostic technologies. Fertility laboratory systems, cryogenic equipment, electronic witnessing, micromanipulation, embryo imaging, cervical screening instruments, molecular workflow devices, and point-of-care diagnostics support precision and reproducibility. Growth is driven by clinic consolidation and the need to standardize multi-site operations. Integration with laboratory information systems and quality management platforms is becoming a competitive requirement.
Connected, wearable, software-enabled, and AI-assisted technologies. This is the fastest-growing technology type. It includes wearable breast pumps, connected fertility monitors, remote pregnancy surveillance, pelvic floor trainers, digital therapeutics with device components, AI imaging software, and patient-facing monitoring tools. Adoption is strongest when the technology reduces staff burden or creates actionable clinical data. Privacy, cybersecurity, algorithm performance, and interoperability will determine long-term trust.

By End User

Hospitals and integrated delivery networks. Hospitals remain the dominant end users because they control high-acuity obstetric care, complex gynecologic surgery, breast oncology, advanced imaging, and inpatient maternal services. Large systems negotiate enterprise agreements, standardize vendors, and evaluate new products through value analysis committees. Their purchasing decisions are influenced by service coverage, capital financing, cybersecurity, clinical education, and compatibility with existing imaging and surgical platforms.
Women’s imaging centers and diagnostic networks. These providers account for a major share of mammography, tomosynthesis, breast ultrasound, bone densitometry, and image-guided biopsy. Independent and health-system-owned networks prioritize throughput, patient experience, radiologist productivity, and dependable service. AI tools, same-day workup, automated quality control, and efficient prior-image management are becoming important differentiators.
OB/GYN practices, fertility clinics, and specialty women’s health centers. This group is central to office-based hysteroscopy, ultrasound, fertility treatment, contraception, menopause care, and pelvic health. Multi-site practices are becoming more influential as physician groups consolidate. They favor compact systems, predictable disposables, easy training, and reimbursement support. Fertility networks place additional emphasis on laboratory standardization, environmental control, and traceability.
Ambulatory surgery centers and office-based procedure suites. ASCs are growing end users for selected gynecologic surgery, hysteroscopy, ablation, breast procedures, and pelvic interventions. The economic model favors rapid turnover, low sterilization burden, limited capital footprint, and reliable case scheduling. Single-use visualization, procedure kits, portable imaging, and technologies that reduce anesthesia requirements are particularly well aligned with this setting.
Home healthcare, pharmacies, and individual consumers. Home-use adoption is expanding in fertility tracking, lactation, pelvic floor rehabilitation, remote pregnancy monitoring, menopause management, and selected diagnostic testing. Consumer channels can accelerate scale, but companies must demonstrate safety, clarity of use, and responsible data practices. Clinical partnerships and referral pathways are important because many products create greater value when patient-generated data can be reviewed by professionals.

By Life Stage

Adolescent and early reproductive health. Demand in this stage is centered on menstrual health, contraception, pelvic pain assessment, ultrasound, cervical prevention pathways, and digital symptom tracking. Growth is influenced by access to primary and specialty care, privacy concerns, and the need for age-appropriate product design. Devices that support early diagnosis of endometriosis and other chronic pelvic conditions address an important unmet need.
Reproductive-age and fertility-focused care. This is the largest life-stage segment because it includes contraception, infertility, benign gynecologic disease, breast screening in higher-risk women, and preconception care. It supports both high-volume consumables and premium procedure platforms. Delayed childbearing and higher use of fertility services are increasing the intensity of device use per patient.
Pregnancy, childbirth, and postpartum. This segment is supported by millions of annual births and includes ultrasound, fetal and maternal monitoring, labor and delivery equipment, postpartum hemorrhage management, lactation devices, and remote postpartum surveillance. Health systems are prioritizing technologies that reduce preventable deterioration, improve documentation, and extend follow-up beyond hospital discharge.
Perimenopause and menopause. Demand is expanding as women seek better evaluation and management of abnormal bleeding, pelvic floor symptoms, vasomotor symptoms, genitourinary changes, and bone loss. The market opportunity extends beyond pharmaceuticals to imaging, diagnostics, minimally invasive uterine treatment, pelvic health, and connected monitoring. Providers increasingly view menopause as a longitudinal service line rather than a single visit.
Older women and healthy aging. This segment is driven by breast cancer screening, osteoporosis, pelvic organ dysfunction, urinary incontinence, and chronic disease monitoring. Women outnumber men at older ages, creating a large long-duration patient base. Devices that improve mobility, reduce fracture risk, simplify screening, and support home-based management will gain relevance as care shifts toward aging in place.

Regional Insights: Where the Market is Growing Fastest

The U.S. Women’s Health Devices Market is geographically segmented into the South, Northeast, West, and Midwest. Regional performance differs according to female population size, birth volume, age distribution, specialist density, mammography infrastructure, fertility clinic concentration, hospital capital intensity, payer mix, state-level reproductive health policy, rural access, and outpatient procedure penetration. The South is the largest regional market in 2025, while the West is expected to record the fastest growth through 2035. The Northeast remains the highest-value region for advanced academic care, and the Midwest provides a stable base of imaging, obstetric, gynecologic, and pelvic health demand.

South

The South is the dominant regional market, accounting for an estimated USD 9.75 billion in 2025. The region includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Its leadership is supported by the country’s largest regional population, high annual birth volume, rapid growth in older adults, significant chronic disease and maternal risk burden, and continued expansion of health systems in major metropolitan areas. The region also contains large rural populations, creating demand for portable imaging, remote monitoring, and hub-and-spoke referral models.

Texas and Florida are the two most commercially important state markets in the South. Texas combines very high birth volume with major medical hubs in Houston, Dallas–Fort Worth, Austin, and San Antonio. It supports large obstetric departments, high-volume fertility clinics, breast imaging networks, academic gynecology programs, and rapidly expanding ambulatory surgery capacity. Florida has one of the largest older female populations in the country, supporting mammography, breast biopsy, osteoporosis assessment, pelvic floor treatment, and menopause-related care. Its population growth also sustains demand for maternity and fertility services in large urban markets.

North Carolina, Georgia, Tennessee, and Virginia are attractive growth states because of health system consolidation, expanding suburban populations, and strong specialist centers. North Carolina has a significant research and academic ecosystem that supports maternal-fetal medicine, fertility, breast imaging, and gynecologic oncology. Georgia’s Atlanta market is a regional referral center, while Tennessee benefits from large hospital operators and strong outpatient surgery infrastructure. Virginia combines affluent metropolitan markets with rural access gaps, creating opportunities for both premium platforms and decentralized care.

Maryland and Delaware benefit from high specialist access and proximity to major academic networks, while South Carolina is expanding women’s imaging and obstetric capacity in fast-growing coastal and metropolitan areas. Alabama, Mississippi, Louisiana, Arkansas, Kentucky, Oklahoma, and West Virginia have substantial maternal and chronic disease needs but uneven access to advanced women’s health services. In these states, manufacturers can address two distinct opportunities: high-value equipment in tertiary referral centers and lower-cost portable or connected technologies for community hospitals and rural clinics.

The South is expected to remain the largest regional market through 2035, reaching approximately USD 24.90 billion. Growth will be driven by population expansion, replacement of mammography and ultrasound systems, rising fertility treatment volume, ambulatory gynecology, increased pelvic health awareness, and investment in maternal risk surveillance. Success in the region will require flexible contracting, strong field service coverage, and solutions that work across both large integrated delivery networks and smaller community facilities.

West

The West represented an estimated USD 5.78 billion in 2025 and is expected to be the fastest-growing region through 2035. It includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. The region combines a powerful technology ecosystem, high consumer adoption of digital health, major academic systems, and rapidly growing populations in several states. It is particularly influential in AI-enabled imaging, fertility innovation, connected monitoring, portable ultrasound, and direct-to-consumer women’s health devices.

California is the largest state market in the West and one of the most strategically important women’s health device markets nationally. Its scale supports dense networks of mammography facilities, fertility clinics, academic medical centers, ambulatory surgery centers, and technology developers. California is often an early commercial market for AI-supported imaging, remote patient monitoring, advanced reproductive technology, and minimally invasive gynecologic platforms. However, procurement is highly competitive, and manufacturers must demonstrate health equity, privacy, interoperability, and economic value.

Arizona and Nevada are high-growth markets because of rapid population expansion and increasing numbers of older residents. Demand is rising for breast imaging, DXA, pelvic health, gynecologic surgery, and obstetric services. Colorado and Utah have strong integrated delivery networks and high adoption of digital care models, while Washington and Oregon are important for enterprise-level imaging, academic research, connected maternal care, and evidence-based purchasing. These states are attractive launch markets for technologies that require sophisticated clinical adoption and data integration.

New Mexico, Idaho, Montana, Wyoming, Alaska, and Hawaii are smaller markets but strategically important for portable and remote models. Geographic distance and specialist shortages create a need for handheld ultrasound, tele-imaging, remote pregnancy surveillance, mobile mammography, and referral coordination. Hawaii and Alaska also face unique logistics and service challenges, making device reliability and remote technical support central to procurement. Manufacturers that can combine durable hardware with cloud-based specialist support can build defensible positions.

By 2035, the West is projected to reach approximately USD 15.37 billion and gain national share. Growth will be supported by AI adoption, consumer-oriented women’s health technology, fertility services, advanced breast imaging, ambulatory gynecology, and migration into Arizona, Nevada, Utah, Idaho, and Colorado. The region will remain highly competitive but commercially important for emerging companies seeking early clinical validation and strategic partnerships.

Northeast

The Northeast accounted for an estimated USD 6.04 billion in 2025 and remains the highest-value region on a per-patient and per-procedure basis. The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania. Its strength is driven by dense academic medical networks, advanced breast centers, specialist fertility programs, high-complexity gynecologic care, and rigorous hospital procurement. The region is also important for clinical trials, physician training, and early evaluation of new devices.

New York is the largest state market in the Northeast, supported by a large and diverse female population, major health systems, high mammography volume, extensive fertility services, and sophisticated gynecologic oncology programs. New Jersey benefits from high insurance coverage, strong outpatient networks, and proximity to major life sciences companies. Pennsylvania combines large urban health systems in Philadelphia and Pittsburgh with extensive community hospital networks, creating demand across premium capital equipment and cost-efficient procedural devices.

Massachusetts is disproportionately influential because of its academic hospitals, medical technology ecosystem, and clinical research capacity. It is an early-adoption market for breast imaging AI, fertility laboratory technology, robotic gynecology, and complex maternal-fetal care. Connecticut and Rhode Island provide concentrated, high-value provider markets, while New Hampshire, Vermont, and Maine have smaller populations but important needs in mobile imaging, rural obstetric access, telehealth-supported pregnancy care, and aging-related women’s health.

Procurement in the Northeast is evidence-intensive. Health systems commonly require strong clinical data, integration with enterprise IT, cybersecurity review, and detailed health economic analysis. Prices may be pressured by large purchasing organizations, but premium technologies can succeed when they improve specialist productivity, reduce repeat procedures, or enable a differentiated regional service line. The concentration of teaching hospitals also makes the region important for training and national diffusion.

The Northeast is expected to reach approximately USD 14.55 billion by 2035. Growth will be slightly below the West because of slower population expansion, but the region will remain highly profitable due to complex procedures, premium imaging adoption, fertility concentration, and strong academic influence. Manufacturers seeking national credibility will continue to prioritize leading centers in New York, Massachusetts, Pennsylvania, and New Jersey.

Midwest

The Midwest represented an estimated USD 4.68 billion in 2025 and is expected to show steady, durable growth through 2035. It includes Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota. The region has a mature hospital infrastructure, major community health systems, important academic centers, and substantial demand for breast screening, obstetric services, benign gynecologic treatment, fertility care, and pelvic health. It also includes large rural areas where access and service coverage affect technology adoption.

Illinois, Ohio, Michigan, and Minnesota are the leading state markets. Illinois benefits from Chicago’s large academic and community provider base, high imaging volume, and broad outpatient capacity. Ohio has strong health systems with nationally recognized women’s health, breast, and fertility programs. Michigan supports substantial demand for breast imaging and gynecologic procedures across urban and regional networks. Minnesota is strategically important because of its medtech ecosystem, integrated care models, and expertise in imaging, neuromodulation, and reproductive health.

Wisconsin, Indiana, and Missouri provide stable demand through large integrated delivery networks and regional referral centers. Iowa, Kansas, Nebraska, North Dakota, and South Dakota are smaller markets but important for maternal access, mobile imaging, portable ultrasound, and remote specialty support. In rural areas, labor and delivery service closures and long travel distances can increase the value of technologies that help community clinicians identify risk and coordinate transfer. Serviceability, training, and device uptime are therefore critical commercial factors.

The Midwest tends to reward vendors that provide reliable service, clinically practical products, and disciplined contracting. Buyers often prioritize standardization, total cost of ownership, and long-term vendor relationships over rapid adoption of unproven technology. Nevertheless, major academic centers in Chicago, Cleveland, Columbus, Detroit, Minneapolis, Madison, St. Louis, and Kansas City can serve as early adopters and influence broader regional uptake.

By 2035, the Midwest is projected to reach approximately USD 11.07 billion. Growth will be supported by replacement of mammography and ultrasound fleets, outpatient gynecology, pelvic health treatment, fertility expansion in metropolitan markets, and remote monitoring in rural areas. The region will remain a dependable market for both mature device categories and workflow-focused innovation.

Key Market Players

The U.S. Women’s Health Devices Competitive Landscape is moderately consolidated in major capital categories but remains fragmented across fertility consumables, pelvic health, home-use devices, and digital platforms. Hologic, GE HealthCare, Siemens Healthineers, Philips, and other imaging companies compete for women’s imaging and obstetric capital budgets. CooperSurgical, Organon, Bayer, and specialized reproductive health suppliers compete across fertility, contraception, and office-based gynecology. Medtronic, Boston Scientific, Johnson & Johnson MedTech, Stryker, Olympus, KARL STORZ, and Intuitive Surgical influence the gynecologic surgery and pelvic health ecosystem.

Competition is increasingly platform-based. Manufacturers are combining capital systems with software, service contracts, disposables, clinical education, reimbursement support, and enterprise data integration. In breast health, the ability to connect screening, diagnosis, biopsy, localization, and surgery creates commercial leverage. In fertility, control of laboratory workflow and consumables supports recurring revenue. In pelvic health and gynecology, physician training and patient referral development are often as important as device performance.

Some of the key players in the U.S. Women’s Health Devices industry are

Hologic, Inc.
GE HealthCare Technologies Inc.
Siemens Healthineers AG
Koninklijke Philips N.V.
The Cooper Companies, Inc. (CooperSurgical)
Becton, Dickinson and Company
Medtronic plc
Boston Scientific Corporation
Johnson & Johnson MedTech
Stryker Corporation
Olympus Corporation
KARL STORZ SE & Co. KG
Intuitive Surgical, Inc.
FUJIFILM Holdings Corporation
Canon Medical Systems Corporation
Samsung Medison Co., Ltd.
Masimo Corporation
Laborie Medical Technologies Corp.
Coloplast A/S
Cook Medical LLC
Minerva Surgical, Inc.
Organon & Co.
Bayer AG
Butterfly Network, Inc.

Hologic is the most women’s-health-focused competitor, with positions across breast imaging, diagnostics, gynecologic surgery, and skeletal health. GE HealthCare, Siemens Healthineers, Philips, Canon Medical, FUJIFILM, Samsung Medison, and Butterfly Network compete in imaging and ultrasound, with increasing emphasis on AI, portability, and workflow automation. CooperSurgical has broad exposure to fertility, contraception, obstetrics, and office-based gynecology. Boston Scientific’s pelvic health position strengthened through its acquisition of Axonics, while Laborie and Coloplast remain important in pelvic floor and continence care.

Market share through 2035 will be influenced by FDA clearances and approvals, clinical evidence, installed-base conversion, physician training capacity, service reliability, consumable pull-through, cybersecurity, and payer support. Companies that can demonstrate measurable improvements in diagnostic turnaround, procedure time, patient recovery, treatment access, or adverse-event reduction will be best positioned to defend premium pricing. The competitive advantage will increasingly belong to companies that understand the full care pathway rather than a single device category.

Recent Developments

Recent developments in the U.S. Women’s Health Devices Market show a strong shift toward regulatory-driven imaging modernization, minimally invasive gynecology, pelvic health consolidation, and connected diagnostics. In September 2024, updated federal mammography requirements became fully effective, including standardized breast density notification. This change increased the strategic importance of automated density assessment, patient communication, supplemental imaging pathways, and enterprise quality controls across the national mammography installed base.

In breast imaging, manufacturers continued to expand AI-enabled detection and workflow tools. Newer software is being positioned to help radiologists prioritize cases, identify suspicious findings, standardize density assessment, and manage increasingly complex tomosynthesis datasets. The commercial value of these tools is tied to the scale of U.S. screening: more than 43 million annual mammography procedures were reported in early 2025. Hospitals and imaging networks are evaluating AI not only for diagnostic performance but also for reading efficiency and workforce resilience.

In gynecology, Hologic completed its acquisition of Gynesonics in early 2025, adding the incisionless, ultrasound-guided Sonata system for treatment of symptomatic uterine fibroids. The transaction reflects the strategic value of uterus-preserving and outpatient-compatible technologies. It also demonstrates how larger women’s health companies are using acquisitions to expand beyond screening and diagnostics into therapeutic pathways with recurring procedural revenue.

Pelvic health consolidation accelerated when Boston Scientific completed its acquisition of Axonics in November 2024. The transaction added sacral neuromodulation and pelvic health products for urinary and bowel dysfunction and pelvic organ prolapse. This move increased competitive scale in a market characterized by high prevalence, low treatment penetration, and growing demand for durable implantable and office-based therapies.

CooperSurgical expanded its medical device portfolio through acquisitions involving obstetric, Doppler monitoring, gynecology surgery, illuminated surgical devices, and fertility-related technologies. These transactions support a broader strategy of controlling more of the reproductive and procedural workflow. Across the market, consolidation is increasing the ability of large suppliers to bundle products, standardize multi-site accounts, and provide clinical education across fertility clinics, OB/GYN practices, hospitals, and ambulatory centers.

The regulatory pipeline also shows continued development of portable ultrasound, AI-assisted fetal imaging, wearable breast pumps, breast density software, and connected home-use products. These technologies are broadening access and creating new commercial channels, but they also raise higher expectations for usability, cybersecurity, data privacy, and post-market evidence. The companies that convert consumer convenience into clinically reliable workflow integration will capture the most durable growth.

Conclusion

The U.S. Women’s Health Devices Market Size & Share is positioned for strong expansion from USD 26.25 billion in 2025 to USD 65.89 billion by 2035, supported by a 9.64% CAGR during the forecast period. The market’s long-term strength is grounded in recurring screening demand, millions of annual births, increasing fertility treatment intensity, high prevalence of benign gynecologic disease, an aging female population, and persistent underdiagnosis in pelvic and menopausal health.

The most attractive growth opportunities will come from AI-enabled breast imaging, image-guided biopsy and localization, minimally invasive fibroid and abnormal bleeding treatment, fertility laboratory automation, portable obstetric ultrasound, connected maternal monitoring, pelvic neuromodulation, home-use lactation products, and integrated menopause and bone health pathways. Mature categories such as mammography, fetal monitoring, hysteroscopy, and contraceptive devices will remain important, but value growth will increasingly depend on software, consumables, interoperability, and evidence-based workflow improvement.

Regional opportunity will be led by the South because of population scale, birth volume, and health system expansion, followed by the Northeast’s high-acuity academic market, the West’s technology-driven adoption, and the Midwest’s stable provider infrastructure. Texas, Florida, California, New York, Pennsylvania, New Jersey, Massachusetts, Illinois, Ohio, North Carolina, Georgia, Arizona, Michigan, Minnesota, and Virginia will remain especially important for manufacturers, distributors, fertility networks, imaging companies, and investors.

For clients evaluating this market, the central question is not whether demand for women’s health devices will grow. The more important questions are which care pathways will shift toward outpatient and home settings, how quickly AI will change imaging economics, which minimally invasive technologies will replace major surgery, and how state-level access and reimbursement differences will affect adoption. Companies that combine differentiated devices, clinical workflow understanding, reimbursement support, responsible data practices, and real-world evidence will define the next decade of the U.S. women’s health devices industry.

TABLE OF CONTENT

1. U.S. Women’s Health Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing, Triangulation & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Women’s Health Device Manufacturers
1.6.2. Component, Consumable, and Contract Manufacturing Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Women’s Imaging Centers and Diagnostic Networks
1.6.5. OB/GYN Practices, Fertility Clinics, and Specialty Centers
1.6.6. Ambulatory Surgery Centers and Office-Based Procedure Suites
1.6.7. Group Purchasing Organizations, Distributors, and Retail Channels
1.6.8. Payers, Regulators, Professional Societies, and Clinical Decision-Makers
What this section provides: This section defines the market boundary, study scope, research methodology, assumptions, and stakeholder ecosystem so clients understand how the U.S. women’s health devices market is measured, segmented, and validated.

2. U.S. Women’s Health Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. High-Growth Opportunity Areas
2.8. Strategic Implications for Manufacturers, Providers, and Investors
What this section provides: This section gives decision-makers a concise view of market size, growth direction, major clinical demand pockets, competitive intensity, investment relevance, and priority opportunity areas through 2035.

3. U.S. Women’s Health Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expanding Breast Cancer Screening and Dense Breast Assessment
3.1.2. High Burden of Uterine Fibroids, Endometriosis, and Abnormal Uterine Bleeding
3.1.3. Rising Fertility Treatment Intensity and Delayed Childbearing
3.1.4. Maternal-Fetal Monitoring Demand and Maternal Outcome Improvement Priorities
3.1.5. Growing Pelvic Floor, Menopause, and Healthy Aging Needs
3.1.6. Migration of Gynecologic Procedures to Outpatient and Office-Based Settings
3.1.7. Adoption of Connected, Home-Use, and AI-Enabled Women’s Health Technologies
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Equipment and Procedure Costs
3.2.2. Reimbursement Variability and Value Analysis Scrutiny
3.2.3. Fragmented Women’s Health Care Pathways and Delayed Diagnosis
3.2.4. Specialist, Sonographer, Radiologist, and Laboratory Workforce Constraints
3.2.5. Product Safety, Recall, Litigation, and Post-Market Surveillance Risks
3.2.6. Data Privacy, Cybersecurity, and Reproductive Health Information Concerns
3.3. Opportunities and Their Impact Analysis
3.3.1. AI-Assisted Breast Imaging and Risk-Stratified Screening
3.3.2. Minimally Invasive Fibroid and Abnormal Uterine Bleeding Treatment
3.3.3. Fertility Laboratory Automation and Workflow Standardization
3.3.4. Wireless Maternal-Fetal and Remote Postpartum Monitoring
3.3.5. Pelvic Neuromodulation and Office-Based Urogynecology
3.3.6. Menopause, Bone Health, Lactation, and Home-Use Device Expansion
3.4. Challenges and Their Impact Analysis
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Hospital Capital Procurement Behavior Analysis
3.8. Patient Access, Health Equity, and Rural Care Analysis
What this section provides: This section explains the clinical, commercial, reimbursement, operational, and patient-access forces shaping demand, helping clients evaluate growth opportunities, adoption barriers, and execution risks.

4. U.S. Women’s Health Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Impact of Digitalization, Femtech, and Connected Women’s Care
4.6. Application & Innovation Landscape
4.7. FDA Regulatory Framework Analysis
4.8. CMS Reimbursement and Coverage Landscape
4.9. Mammography Quality Standards and Breast Density Notification Framework
4.10. Import/Export Restrictions, Tariffs, and Component Supply Risk
4.11. Government Initiatives and Women’s Health Research Programs
4.12. Impact of Escalating Geopolitical Tensions
4.13. Hospital Value Analysis Committee Decision Framework
4.14. Sensitive Health Data Governance and Cybersecurity Framework
What this section provides: This section gives clients a complete view of the external market environment, including regulation, reimbursement, pricing, supply chains, technology adoption, sensitive-data governance, and hospital procurement dynamics.

5. U.S. Women’s Health Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
5.2. Breast Health Imaging, Biopsy, and Intervention Devices
5.2.1. Digital Mammography and Digital Breast Tomosynthesis Systems
5.2.2. Breast Ultrasound, MRI, and Supplemental Imaging Systems
5.2.3. Breast Imaging AI, Density Assessment, and Workflow Software
5.2.4. Breast Biopsy, Localization, and Specimen Imaging Devices
5.3. Gynecological Surgical and Therapeutic Devices
5.3.1. Hysteroscopy, Resectoscopy, and Tissue Removal Systems
5.3.2. Fibroid Ablation and Uterus-Preserving Treatment Devices
5.3.3. Endometrial Ablation Systems
5.3.4. Laparoscopy, Robotic Surgery, Advanced Energy, and Fluid Management Devices
5.3.5. Colposcopy, Cervical Biopsy, and Gynecologic Diagnostic Devices
5.4. Reproductive Health, Fertility, and Contraceptive Devices
5.4.1. IVF Incubators and Fertility Laboratory Equipment
5.4.2. Gamete and Embryo Micromanipulation, Aspiration, and Transfer Devices
5.4.3. Cryostorage, Electronic Witnessing, and Laboratory Traceability Systems
5.4.4. Fertility Diagnostics, Ovulation Testing, and Home Monitoring Devices
5.4.5. Intrauterine, Implantable, and Sterilization Devices
5.5. Pregnancy, Labor, Maternal, and Fetal Monitoring Devices
5.5.1. Obstetric Ultrasound Systems
5.5.2. Fetal Monitoring and Maternal Surveillance Systems
5.5.3. Labor and Delivery, Operative Delivery, and Cesarean Support Devices
5.5.4. Postpartum Hemorrhage Management Devices
5.5.5. Remote Pregnancy and Postpartum Monitoring Devices
5.6. Pelvic Floor and Urogynecology Devices
5.6.1. Sacral and Tibial Neuromodulation Systems
5.6.2. Slings and Pelvic Organ Prolapse Repair Devices
5.6.3. Pessaries, Bulking Agents, and Vaginal Support Devices
5.6.4. Urodynamic and Pelvic Floor Diagnostic Systems
5.6.5. Biofeedback and Connected Pelvic Floor Rehabilitation Devices
5.7. Bone Health, Menopause, Lactation, and Home-Use Devices
5.7.1. DXA Bone Densitometry and Body Composition Systems
5.7.2. Breast Pumps and Lactation Support Devices
5.7.3. Menopause and Genitourinary Health Devices
5.7.4. Home Diagnostic, Wearable, and Consumer-Mediated Medical Devices
What this section provides: This section identifies which women’s health device categories and subcategories are expected to generate the highest revenue contribution, recurring consumable demand, and strongest growth through 2035.

6. U.S. Women’s Health Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
6.2. Breast Cancer Screening, Diagnosis, and Treatment Support
6.2.1. Routine and Risk-Based Screening
6.2.2. Dense Breast and Supplemental Imaging
6.2.3. Image-Guided Biopsy and Lesion Localization
6.2.4. Breast Surgery and Treatment Planning Support
6.3. Uterine, Cervical, Ovarian, and Benign Gynecologic Disorder Management
6.3.1. Uterine Fibroids and Abnormal Uterine Bleeding
6.3.2. Endometriosis and Chronic Pelvic Pain
6.3.3. Cervical Disease and Colposcopic Evaluation
6.3.4. Adnexal, Ovarian, and Gynecologic Oncology Procedures
6.4. Fertility, Assisted Reproduction, and Family Planning
6.4.1. Infertility Diagnosis and Ovarian Reserve Assessment
6.4.2. Ovum Retrieval, Fertilization, Culture, and Embryo Transfer
6.4.3. Cryopreservation and Fertility Preservation
6.4.4. Contraception and Permanent Birth Control
6.5. Pregnancy, Childbirth, and Postpartum Care
6.5.1. Routine Obstetric Imaging and Fetal Assessment
6.5.2. High-Risk Pregnancy and Maternal-Fetal Surveillance
6.5.3. Intrapartum Monitoring and Operative Delivery
6.5.4. Postpartum Hemorrhage and Maternal Recovery
6.5.5. Remote Postpartum and Hypertension Monitoring
6.6. Pelvic Floor Dysfunction, Urinary Incontinence, and Sexual Health
6.6.1. Stress and Urgency Urinary Incontinence
6.6.2. Overactive Bladder and Fecal Incontinence
6.6.3. Pelvic Organ Prolapse
6.6.4. Postpartum Pelvic Floor Rehabilitation
6.7. Menopause, Osteoporosis, and Healthy Aging
6.7.1. Bone Density and Fracture Risk Assessment
6.7.2. Genitourinary Syndrome of Menopause
6.7.3. Longitudinal Menopause and Healthy Aging Management
What this section provides: This section helps clients understand demand by clinical use case and prioritize applications with high screening volumes, procedural growth, reimbursement relevance, unmet need, and device innovation.

7. U.S. Women’s Health Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
7.2. Hospitals and Integrated Delivery Networks
7.2.1. Academic Medical Centers and Tertiary Referral Hospitals
7.2.2. Community Hospitals and Regional Health Systems
7.2.3. Labor and Delivery and Maternal-Fetal Medicine Departments
7.3. Women’s Imaging Centers and Diagnostic Networks
7.3.1. Hospital-Owned Imaging Networks
7.3.2. Independent Breast Imaging and Diagnostic Centers
7.3.3. Mobile Mammography and Community Screening Providers
7.4. OB/GYN Practices, Fertility Clinics, and Specialty Women’s Health Centers
7.4.1. Independent and Multi-Site OB/GYN Practices
7.4.2. Fertility and Assisted Reproduction Clinics
7.4.3. Urogynecology, Menopause, and Pelvic Health Centers
7.5. Ambulatory Surgery Centers and Office-Based Procedure Suites
7.5.1. Gynecologic Ambulatory Surgery Centers
7.5.2. Office-Based Hysteroscopy and Procedure Suites
7.5.3. Outpatient Breast Biopsy and Intervention Centers
7.6. Home Healthcare, Pharmacies, Retail Channels, and Individual Consumers
7.6.1. Home Healthcare and Remote Monitoring Providers
7.6.2. Pharmacies, Specialty Distributors, and Retail Channels
7.6.3. Direct-to-Consumer and Subscription-Based Care Models
What this section provides: This section explains which care settings and customer groups are expected to drive capital purchasing, procedure adoption, recurring consumable use, remote monitoring, and consumer-mediated device demand.

8. U.S. Women’s Health Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
8.2. Imaging and Image-Guided Technologies
8.2.1. X-Ray, Tomosynthesis, Ultrasound, MRI, and DXA Platforms
8.2.2. Optical Visualization, Hysteroscopy, and Colposcopy
8.2.3. Image-Guided Biopsy, Localization, and Therapy
8.3. Minimally Invasive Surgical and Energy-Based Technologies
8.3.1. Radiofrequency, Thermal, Bipolar, and Ultrasonic Energy
8.3.2. Hysteroscopic, Laparoscopic, and Robotic Technologies
8.3.3. Fluid Management and Tissue Extraction Technologies
8.4. Implantable, Disposable, and Procedure-Based Technologies
8.4.1. Contraceptive and Pelvic Health Implants
8.4.2. Neuromodulation Systems
8.4.3. Biopsy, Transfer, Aspiration, and Procedure Consumables
8.5. Laboratory Automation and Diagnostic Technologies
8.5.1. Fertility Laboratory and Embryology Systems
8.5.2. Cryogenic Storage, Electronic Witnessing, and Traceability
8.5.3. Point-of-Care and Home Diagnostic Technologies
8.6. Connected, Wearable, Software-Enabled, and AI-Assisted Technologies
8.6.1. AI-Assisted Breast and Obstetric Imaging
8.6.2. Remote Maternal and Postpartum Monitoring
8.6.3. Connected Fertility, Lactation, and Pelvic Health Devices
8.6.4. Cloud Platforms, Clinical Analytics, and Workflow Orchestration
What this section provides: This section evaluates the technology platforms reshaping women’s care, including imaging, minimally invasive treatment, implantables, laboratory automation, connected devices, and AI-assisted workflows.

9. U.S. Women’s Health Devices Market – By Life Stage

9.1. Overview
9.1.1. Segment Share Analysis, By Life Stage, 2025 & 2035 (%)
9.1.2. Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
9.2. Adolescent and Early Reproductive Health
9.2.1. Menstrual and Pelvic Health Evaluation
9.2.2. Contraception and Preventive Care
9.2.3. Early Diagnosis of Chronic Gynecologic Conditions
9.3. Reproductive-Age and Fertility-Focused Care
9.3.1. Contraception and Family Planning
9.3.2. Fertility Assessment and Assisted Reproduction
9.3.3. Benign Gynecologic Disease Management
9.4. Pregnancy, Childbirth, and Postpartum
9.4.1. Prenatal Imaging and Pregnancy Monitoring
9.4.2. Labor, Delivery, and Maternal Safety
9.4.3. Postpartum Recovery, Lactation, and Remote Monitoring
9.5. Perimenopause and Menopause
9.5.1. Abnormal Bleeding and Uterine Health
9.5.2. Pelvic Floor and Genitourinary Health
9.5.3. Menopause Monitoring and Longitudinal Care
9.6. Older Women and Healthy Aging
9.6.1. Breast Screening and Cancer Diagnostic Support
9.6.2. Osteoporosis and Fracture Risk Assessment
9.6.3. Pelvic Organ Dysfunction and Continence Care
What this section provides: This section maps device demand across the female life course, helping clients identify how screening, reproductive care, pregnancy, menopause, pelvic health, and healthy aging needs change by patient stage.

10. U.S. Women’s Health Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Screening, Birth, Fertility, and Procedure Volume Analysis
10.1.4. Regional Hospital, Imaging, Fertility Clinic, and Ambulatory Infrastructure Analysis
10.1.5. Regional Reimbursement, Access, and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Women’s Health Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Women’s Health Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Women’s Health Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Women’s Health Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Life Stage, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed regional and state-level analysis for all 50 states, helping clients identify priority geographies, screening and birth-volume hubs, fertility and procedure clusters, technology-adoption hotspots, access gaps, and state-level commercial opportunities.

11. U.S. Women’s Health Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.1.1. Market Share by Major Company
11.1.2. Market Share by Product Category
11.1.3. Competitive Concentration and Fragmentation Analysis
11.2. Company Positioning Matrix
11.2.1. Leaders
11.2.2. Challengers
11.2.3. Innovators
11.2.4. Emerging Players
11.3. Company Profiles
11.3.1. Hologic, Inc.
11.3.2. GE HealthCare Technologies Inc.
11.3.3. Siemens Healthineers AG
11.3.4. Koninklijke Philips N.V.
11.3.5. The Cooper Companies, Inc. (CooperSurgical)
11.3.6. Becton, Dickinson and Company
11.3.7. Medtronic plc
11.3.8. Boston Scientific Corporation
11.3.9. Johnson & Johnson MedTech
11.3.10. Stryker Corporation
11.3.11. Olympus Corporation
11.3.12. KARL STORZ SE & Co. KG
11.3.13. Intuitive Surgical, Inc.
11.3.14. FUJIFILM Holdings Corporation
11.3.15. Canon Medical Systems Corporation
11.3.16. Samsung Medison Co., Ltd.
11.3.17. Masimo Corporation
11.3.18. Laborie Medical Technologies Corp.
11.3.19. Coloplast A/S
11.3.20. Cook Medical LLC
11.3.21. Minerva Surgical, Inc.
11.3.22. Organon & Co.
11.3.23. Bayer AG
11.3.24. Butterfly Network, Inc.
11.3.25. Revvity, Inc.
Note: Each company profile will include company overview, women’s health device portfolio, U.S. market strategy, financial positioning, clinical and innovation pipeline, FDA and regulatory updates, partnerships, acquisitions, and recent developments.
What this section provides: This section gives clients competitor benchmarking, market share visibility, portfolio positioning, innovation direction, acquisition activity, and strategic intelligence on 25 major women’s health device companies.

12. U.S. Women’s Health Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. AI-Assisted Breast Imaging and Personalized Screening
12.2.2. Minimally Invasive and Incisionless Fibroid Treatment
12.2.3. Fertility Laboratory Automation and AI-Enabled Embryology
12.2.4. Portable Obstetric Ultrasound and Wireless Maternal-Fetal Monitoring
12.2.5. Pelvic Neuromodulation and Connected Rehabilitation
12.2.6. Home Diagnostics, Wearables, and Consumer-Clinical Data Integration
12.3. Emerging Business Trends
12.3.1. Women’s Health Platform Consolidation
12.3.2. Procedure Migration to Ambulatory and Office-Based Settings
12.3.3. Enterprise Imaging and Multi-Site Fertility Standardization
12.3.4. Subscription, Service, and Recurring Consumable Models
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Technology Adoption Timeline, 2026–2035
What this section provides: This section prepares clients for future technology shifts, market structure changes, business-model evolution, investment opportunities, and realistic adoption scenarios through 2035.

13. U.S. Women’s Health Devices Market: Strategic Recommendations

13.1. Recommendations for Women’s Health Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Delivery Networks
13.3. Recommendations for Women’s Imaging and Fertility Networks
13.4. Recommendations for Investors and Private Equity Firms
13.5. Recommendations for Distributors and Channel Partners
13.6. Recommendations for New Entrants and Startups
13.7. Go-to-Market Strategy Considerations
13.8. Product Positioning and Portfolio Expansion Guidance
13.9. Reimbursement, Evidence Generation, and Market Access Guidance
13.10. State and Regional Commercial Prioritization Framework
What this section provides: This section converts market intelligence into actionable strategy for product development, evidence generation, market access, channel expansion, regional prioritization, investment decisions, and competitive differentiation.

14. U.S. Women’s Health Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Forecasting Limitation
14.4. Legal Disclaimer
14.5. Third-Party Data Disclaimer
14.6. Regulatory and Reimbursement Change Disclaimer
What this section provides: This section clarifies the report’s limitations, legal boundaries, data-use terms, forecast assumptions, and the potential impact of future regulatory, reimbursement, and market changes.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Women’s Health Devices Market: Market Definition and Scope
TABLE 3: U.S. Women’s Health Devices Market: Research Methodology Framework
TABLE 4: U.S. Women’s Health Devices Market: Key Assumptions
TABLE 5: U.S. Women’s Health Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Women’s Health Devices Market: Stakeholder Analysis
TABLE 7: U.S. Women’s Health Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Women’s Health Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Women’s Health Devices Market: Market Attractiveness Index
TABLE 10: U.S. Women’s Health Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Women’s Health Devices Market: Base Year Market Positioning, 2025
TABLE 12: U.S. Women’s Health Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 13: U.S. Women’s Health Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 14: U.S. Women’s Health Devices Market: High-Growth Opportunity Areas
TABLE 15: U.S. Women’s Health Devices Market: Strategic Implications for Manufacturers, Providers, and Investors
TABLE 16: U.S. Women’s Health Devices Market: Drivers; Impact Analysis
TABLE 17: U.S. Women’s Health Devices Market: Restraints; Impact Analysis
TABLE 18: U.S. Women’s Health Devices Market: Opportunities; Impact Analysis
TABLE 19: U.S. Women’s Health Devices Market: Challenges; Impact Analysis
TABLE 20: U.S. Women’s Health Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 21: U.S. Women’s Health Devices Market: Clinical Workflow Economics Matrix
TABLE 22: U.S. Women’s Health Devices Market: Hospital Capital Procurement Behavior Matrix
TABLE 23: U.S. Women’s Health Devices Market: Patient Access, Health Equity, and Rural Care Matrix
TABLE 24: U.S. Women’s Health Devices Market: PESTEL Analysis
TABLE 25: U.S. Women’s Health Devices Market: Porter’s Five Forces Analysis
TABLE 26: U.S. Women’s Health Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 27: U.S. Women’s Health Devices Market: Value Chain Analysis
TABLE 28: U.S. Women’s Health Devices Market: Supply Chain Analysis
TABLE 29: U.S. Women’s Health Devices Market: Digitalization, Femtech, and Connected Women’s Care Impact
TABLE 30: U.S. Women’s Health Devices Market: Application & Innovation Landscape
TABLE 31: U.S. Women’s Health Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Women’s Health Devices Market: CMS Reimbursement and Coverage Landscape
TABLE 33: U.S. Women’s Health Devices Market: Mammography Quality Standards and Breast Density Notification Framework
TABLE 34: U.S. Women’s Health Devices Market: Import/Export Restrictions, Tariffs, and Component Supply Risk
TABLE 35: U.S. Women’s Health Devices Market: Government Initiatives and Women’s Health Research Programs
TABLE 36: U.S. Women’s Health Devices Market: Impact of Escalating Geopolitical Tensions
TABLE 37: U.S. Women’s Health Devices Market: Hospital Value Analysis Committee Decision Framework
TABLE 38: U.S. Women’s Health Devices Market: Sensitive Health Data Governance and Cybersecurity Framework
TABLE 39: U.S. Women’s Health Devices Market: Product Category Snapshot, 2025
TABLE 40: Segment Dashboard; Definition and Scope, by Product Category
TABLE 41: U.S. Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 42: U.S. Women’s Health Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 43: U.S. Women’s Health Devices Market: Breast Health Imaging, Biopsy, and Intervention Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Women’s Health Devices Market: Gynecological Surgical and Therapeutic Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Women’s Health Devices Market: Reproductive Health, Fertility, and Contraceptive Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Women’s Health Devices Market: Pregnancy, Labor, Maternal, and Fetal Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 47: U.S. Women’s Health Devices Market: Pelvic Floor and Urogynecology Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 48: U.S. Women’s Health Devices Market: Bone Health, Menopause, Lactation, and Home-Use Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 49: U.S. Women’s Health Devices Market: Application Snapshot, 2025
TABLE 50: Segment Dashboard; Definition and Scope, by Application
TABLE 51: U.S. Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 52: U.S. Women’s Health Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 53: U.S. Women’s Health Devices Market: Breast Cancer Screening, Diagnosis, and Treatment Support Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Women’s Health Devices Market: Uterine, Cervical, Ovarian, and Benign Gynecologic Disorder Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Women’s Health Devices Market: Fertility, Assisted Reproduction, and Family Planning Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Women’s Health Devices Market: Pregnancy, Childbirth, and Postpartum Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Women’s Health Devices Market: Pelvic Floor Dysfunction, Urinary Incontinence, and Sexual Health Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Women’s Health Devices Market: Menopause, Osteoporosis, and Healthy Aging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: U.S. Women’s Health Devices Market: End User Snapshot, 2025
TABLE 60: Segment Dashboard; Definition and Scope, by End User
TABLE 61: U.S. Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 62: U.S. Women’s Health Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 63: U.S. Women’s Health Devices Market: Hospitals and Integrated Delivery Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Women’s Health Devices Market: Women’s Imaging Centers and Diagnostic Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Women’s Health Devices Market: OB/GYN Practices, Fertility Clinics, and Specialty Women’s Health Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Women’s Health Devices Market: Ambulatory Surgery Centers and Office-Based Procedure Suites Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Women’s Health Devices Market: Home Healthcare, Pharmacies, Retail Channels, and Individual Consumers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Women’s Health Devices Market: Technology Type Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 70: U.S. Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 71: U.S. Women’s Health Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 72: U.S. Women’s Health Devices Market: Imaging and Image-Guided Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Women’s Health Devices Market: Minimally Invasive Surgical and Energy-Based Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Women’s Health Devices Market: Implantable, Disposable, and Procedure-Based Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Women’s Health Devices Market: Laboratory Automation and Diagnostic Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Women’s Health Devices Market: Connected, Wearable, Software-Enabled, and AI-Assisted Technologies Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Women’s Health Devices Market: Life Stage Snapshot, 2025
TABLE 78: Segment Dashboard; Definition and Scope, by Life Stage
TABLE 79: U.S. Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 80: U.S. Women’s Health Devices Market: Segment Share Analysis, by Life Stage, 2025 & 2035 (%)
TABLE 81: U.S. Women’s Health Devices Market: Adolescent and Early Reproductive Health Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: U.S. Women’s Health Devices Market: Reproductive-Age and Fertility-Focused Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Women’s Health Devices Market: Pregnancy, Childbirth, and Postpartum Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Women’s Health Devices Market: Perimenopause and Menopause Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Women’s Health Devices Market: Older Women and Healthy Aging Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Women’s Health Devices Market: Regional Snapshot, 2025
TABLE 87: Segment Dashboard; Definition and Scope, by Region
TABLE 88: U.S. Women’s Health Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 89: U.S. Women’s Health Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 90: West Region U.S. Women’s Health Devices Market: Regional Overview and Trends
TABLE 91: West Region U.S. Women’s Health Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 92: West Region U.S. Women’s Health Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 93: West Region U.S. Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 94: West Region U.S. Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 98: California Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 99: California Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 100: California Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 101: California Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 102: California Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 103: Washington Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 104: Washington Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 105: Washington Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 106: Washington Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 107: Washington Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 108: Arizona Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 109: Arizona Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 110: Arizona Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 111: Arizona Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 112: Arizona Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 113: Colorado Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 114: Colorado Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 115: Colorado Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 116: Colorado Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 117: Colorado Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 118: Oregon Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 119: Oregon Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 120: Oregon Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 121: Oregon Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 122: Oregon Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 123: Utah Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 124: Utah Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 125: Utah Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 126: Utah Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 127: Utah Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 128: Nevada Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 129: Nevada Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 130: Nevada Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 131: Nevada Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 132: Nevada Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 133: New Mexico Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 134: New Mexico Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 138: Idaho Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 139: Idaho Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 140: Idaho Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 141: Idaho Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 142: Idaho Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 143: Montana Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 144: Montana Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 145: Montana Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 146: Montana Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 147: Montana Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 148: Wyoming Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 149: Wyoming Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 153: Alaska Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 154: Alaska Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 155: Alaska Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 156: Alaska Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 157: Alaska Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 158: Hawaii Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 159: Hawaii Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 163: Northeast Region U.S. Women’s Health Devices Market: Regional Overview and Trends
TABLE 164: Northeast Region U.S. Women’s Health Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 165: Northeast Region U.S. Women’s Health Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 166: Northeast Region U.S. Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 167: Northeast Region U.S. Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 171: New York Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 172: New York Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 173: New York Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 174: New York Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 175: New York Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 176: Massachusetts Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 177: Massachusetts Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 181: New Jersey Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 182: New Jersey Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 186: Pennsylvania Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 187: Pennsylvania Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 191: Connecticut Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 192: Connecticut Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 196: Maine Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 197: Maine Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 198: Maine Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 199: Maine Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 200: Maine Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 201: Vermont Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 202: Vermont Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 203: Vermont Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 204: Vermont Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 205: Vermont Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 206: New Hampshire Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 207: New Hampshire Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 211: Rhode Island Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 212: Rhode Island Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 216: Delaware Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 217: Delaware Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 218: Delaware Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 219: Delaware Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 220: Delaware Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 221: South Region U.S. Women’s Health Devices Market: Regional Overview and Trends
TABLE 222: South Region U.S. Women’s Health Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 223: South Region U.S. Women’s Health Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 224: South Region U.S. Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 225: South Region U.S. Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 229: Texas Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 230: Texas Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 231: Texas Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 232: Texas Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 233: Texas Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 234: Florida Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 235: Florida Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 236: Florida Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 237: Florida Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 238: Florida Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 239: Georgia Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 240: Georgia Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 241: Georgia Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 242: Georgia Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 243: Georgia Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 244: North Carolina Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 245: North Carolina Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 249: Tennessee Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 250: Tennessee Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 254: South Carolina Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 255: South Carolina Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 259: Alabama Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 260: Alabama Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 261: Alabama Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 262: Alabama Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 263: Alabama Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 264: Mississippi Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 265: Mississippi Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 269: Louisiana Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 270: Louisiana Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 274: Arkansas Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 275: Arkansas Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 279: Kentucky Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 280: Kentucky Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 284: Oklahoma Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 285: Oklahoma Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 289: Virginia Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 290: Virginia Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 291: Virginia Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 292: Virginia Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 293: Virginia Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 294: Maryland Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 295: Maryland Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 296: Maryland Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 297: Maryland Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 298: Maryland Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 299: West Virginia Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 300: West Virginia Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 304: Midwest Region U.S. Women’s Health Devices Market: Regional Overview and Trends
TABLE 305: Midwest Region U.S. Women’s Health Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 306: Midwest Region U.S. Women’s Health Devices Market, by State, 2021–2035 (US$ Billion)
TABLE 307: Midwest Region U.S. Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 308: Midwest Region U.S. Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 312: Illinois Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 313: Illinois Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 314: Illinois Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 315: Illinois Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 316: Illinois Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 317: Ohio Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 318: Ohio Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 319: Ohio Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 320: Ohio Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 321: Ohio Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 322: Michigan Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 323: Michigan Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 324: Michigan Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 325: Michigan Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 326: Michigan Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 327: Minnesota Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 328: Minnesota Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 332: Indiana Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 333: Indiana Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 334: Indiana Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 335: Indiana Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 336: Indiana Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 337: Wisconsin Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 338: Wisconsin Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 342: Missouri Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 343: Missouri Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 344: Missouri Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 345: Missouri Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 346: Missouri Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 347: Iowa Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 348: Iowa Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 349: Iowa Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 350: Iowa Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 351: Iowa Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 352: Kansas Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 353: Kansas Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 354: Kansas Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 355: Kansas Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 356: Kansas Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 357: Nebraska Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 358: Nebraska Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 362: North Dakota Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 363: North Dakota Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 367: South Dakota Women’s Health Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 368: South Dakota Women’s Health Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Women’s Health Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Women’s Health Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Women’s Health Devices Market, by Life Stage, 2021–2035 (US$ Billion)
TABLE 372: U.S. Women’s Health Devices Market: Competitive Landscape Snapshot, 2025
TABLE 373: U.S. Women’s Health Devices Market: Key Company Market Share Analysis, 2025
TABLE 374: U.S. Women’s Health Devices Market: Market Share Analysis by Product Category, 2025
TABLE 375: U.S. Women’s Health Devices Market: Competitive Concentration and Fragmentation Analysis
TABLE 376: U.S. Women’s Health Devices Market: Company Positioning Matrix
TABLE 377: U.S. Women’s Health Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 378: U.S. Women’s Health Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 379: Hologic, Inc.: Company Profile
TABLE 380: GE HealthCare Technologies Inc.: Company Profile
TABLE 381: Siemens Healthineers AG: Company Profile
TABLE 382: Koninklijke Philips N.V.: Company Profile
TABLE 383: The Cooper Companies, Inc. (CooperSurgical): Company Profile
TABLE 384: Becton, Dickinson and Company: Company Profile
TABLE 385: Medtronic plc: Company Profile
TABLE 386: Boston Scientific Corporation: Company Profile
TABLE 387: Johnson & Johnson MedTech: Company Profile
TABLE 388: Stryker Corporation: Company Profile
TABLE 389: Olympus Corporation: Company Profile
TABLE 390: KARL STORZ SE & Co. KG: Company Profile
TABLE 391: Intuitive Surgical, Inc.: Company Profile
TABLE 392: FUJIFILM Holdings Corporation: Company Profile
TABLE 393: Canon Medical Systems Corporation: Company Profile
TABLE 394: Samsung Medison Co., Ltd.: Company Profile
TABLE 395: Masimo Corporation: Company Profile
TABLE 396: Laborie Medical Technologies Corp.: Company Profile
TABLE 397: Coloplast A/S: Company Profile
TABLE 398: Cook Medical LLC: Company Profile
TABLE 399: Minerva Surgical, Inc.: Company Profile
TABLE 400: Organon & Co.: Company Profile
TABLE 401: Bayer AG: Company Profile
TABLE 402: Butterfly Network, Inc.: Company Profile
TABLE 403: Revvity, Inc.: Company Profile
TABLE 404: U.S. Women’s Health Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Women’s Health Devices Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Women’s Health Devices Market: AI-Assisted Breast Imaging and Personalized Screening Opportunity Matrix
TABLE 407: U.S. Women’s Health Devices Market: Minimally Invasive and Incisionless Fibroid Treatment Adoption Roadmap
TABLE 408: U.S. Women’s Health Devices Market: Fertility Laboratory Automation and AI-Enabled Embryology Opportunity Map
TABLE 409: U.S. Women’s Health Devices Market: Portable Obstetric Ultrasound and Wireless Maternal-Fetal Monitoring Adoption Matrix
TABLE 410: U.S. Women’s Health Devices Market: Pelvic Neuromodulation and Connected Rehabilitation Opportunity Map
TABLE 411: U.S. Women’s Health Devices Market: Home Diagnostics, Wearables, and Consumer-Clinical Data Integration Roadmap
TABLE 412: U.S. Women’s Health Devices Market: Emerging Business Trends
TABLE 413: U.S. Women’s Health Devices Market: Business Opportunities for Startups and Existing Players
TABLE 414: U.S. Women’s Health Devices Market: Investment Prioritization Matrix
TABLE 415: U.S. Women’s Health Devices Market: Technology Adoption Timeline, 2026–2035
TABLE 416: U.S. Women’s Health Devices Market: Strategic Recommendations for Women’s Health Device Manufacturers
TABLE 417: U.S. Women’s Health Devices Market: Strategic Recommendations for Hospitals and Integrated Delivery Networks
TABLE 418: U.S. Women’s Health Devices Market: Strategic Recommendations for Women’s Imaging and Fertility Networks
TABLE 419: U.S. Women’s Health Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 420: U.S. Women’s Health Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 421: U.S. Women’s Health Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 422: U.S. Women’s Health Devices Market: Go-to-Market Strategy Considerations
TABLE 423: U.S. Women’s Health Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 424: U.S. Women’s Health Devices Market: Reimbursement, Evidence Generation, and Market Access Guidance
TABLE 425: U.S. Women’s Health Devices Market: State and Regional Commercial Prioritization Framework
TABLE 426: U.S. Women’s Health Devices Market: Scope Limitation
TABLE 427: U.S. Women’s Health Devices Market: Data Use Limitation
TABLE 428: U.S. Women’s Health Devices Market: Forecasting Limitation
TABLE 429: U.S. Women’s Health Devices Market: Legal Disclaimer
TABLE 430: U.S. Women’s Health Devices Market: Third-Party Data Disclaimer
TABLE 431: U.S. Women’s Health Devices Market: Regulatory and Reimbursement Change Disclaimer

List of Figures

FIGURE 1: U.S. Women’s Health Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: Patient Access, Health Equity, and Rural Care Framework
FIGURE 13: U.S. Women’s Health Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 14: U.S. Women’s Health Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 15: U.S. Women’s Health Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 16: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 17: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Breast Health Imaging, Biopsy, and Intervention Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Gynecological Surgical and Therapeutic Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Reproductive Health, Fertility, and Contraceptive Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Pregnancy, Labor, Maternal, and Fetal Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Pelvic Floor and Urogynecology Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 23: Bone Health, Menopause, Lactation, and Home-Use Devices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Breast Cancer Screening, Diagnosis, and Treatment Support Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Uterine, Cervical, Ovarian, and Benign Gynecologic Disorder Management Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Fertility, Assisted Reproduction, and Family Planning Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Pregnancy, Childbirth, and Postpartum Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Pelvic Floor Dysfunction, Urinary Incontinence, and Sexual Health Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Menopause, Osteoporosis, and Healthy Aging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 33: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Hospitals and Integrated Delivery Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Women’s Imaging Centers and Diagnostic Networks Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: OB/GYN Practices, Fertility Clinics, and Specialty Women’s Health Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Ambulatory Surgery Centers and Office-Based Procedure Suites Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Home Healthcare, Pharmacies, Retail Channels, and Individual Consumers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 40: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Imaging and Image-Guided Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 42: Minimally Invasive Surgical and Energy-Based Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Implantable, Disposable, and Procedure-Based Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: Laboratory Automation and Diagnostic Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Connected, Wearable, Software-Enabled, and AI-Assisted Technologies Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Life Stage Segment Market Share Analysis, 2025 & 2035
FIGURE 47: Life Stage Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Adolescent and Early Reproductive Health Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Reproductive-Age and Fertility-Focused Care Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 50: Pregnancy, Childbirth, and Postpartum Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Perimenopause and Menopause Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Older Women and Healthy Aging Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 54: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: West Region U.S. Women’s Health Devices Market Share and Leading Players, 2025
FIGURE 56: West Region Market Share Analysis by State, 2025
FIGURE 57: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: California Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Washington Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Arizona Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Colorado Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Oregon Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Utah Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Nevada Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: New Mexico Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Idaho Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Montana Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Wyoming Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Alaska Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Hawaii Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Northeast Region U.S. Women’s Health Devices Market Share and Leading Players, 2025
FIGURE 72: Northeast Region Market Share Analysis by State, 2025
FIGURE 73: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: New York Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Massachusetts Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: New Jersey Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 77: Pennsylvania Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Connecticut Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Maine Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Vermont Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: New Hampshire Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Rhode Island Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Delaware Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: South Region U.S. Women’s Health Devices Market Share and Leading Players, 2025
FIGURE 85: South Region Market Share Analysis by State, 2025
FIGURE 86: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Texas Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Florida Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Georgia Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: North Carolina Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Tennessee Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: South Carolina Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Alabama Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: Mississippi Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Louisiana Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Arkansas Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Kentucky Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Oklahoma Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Virginia Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Maryland Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: West Virginia Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Midwest Region U.S. Women’s Health Devices Market Share and Leading Players, 2025
FIGURE 103: Midwest Region Market Share Analysis by State, 2025
FIGURE 104: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: Illinois Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Ohio Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Michigan Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 108: Minnesota Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Indiana Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Wisconsin Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Missouri Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Iowa Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Kansas Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Nebraska Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: North Dakota Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: South Dakota Women’s Health Devices Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 118: Company Positioning Matrix
FIGURE 119: Key Player Product Portfolio Benchmarking
FIGURE 120: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 121: Women’s Health Device Innovation Roadmap
FIGURE 122: AI-Assisted Breast Imaging and Personalized Screening Adoption Roadmap
FIGURE 123: Minimally Invasive Fibroid Treatment Opportunity Map
FIGURE 124: Fertility Laboratory Automation and AI-Enabled Embryology Roadmap
FIGURE 125: Portable Obstetric Ultrasound and Wireless Maternal-Fetal Monitoring Growth Roadmap
FIGURE 126: Pelvic Neuromodulation and Connected Rehabilitation Opportunity Map
FIGURE 127: Home Diagnostics, Wearables, and Consumer-Clinical Data Integration Roadmap
FIGURE 128: Future Market Scenario Analysis, 2026–2035
FIGURE 129: Disruptive Technologies Impact Matrix
FIGURE 130: Emerging Business Trends Matrix
FIGURE 131: Investment Prioritization Matrix
FIGURE 132: Technology Adoption Timeline, 2026–2035
FIGURE 133: Strategic Growth Roadmap for U.S. Women’s Health Device Companies
FIGURE 134: Hospital and Integrated Delivery Network Adoption Framework
FIGURE 135: Women’s Imaging and Fertility Network Expansion Framework
FIGURE 136: Go-to-Market Strategy Framework
FIGURE 137: Product Positioning, Evidence Generation, and Portfolio Expansion Framework
FIGURE 138: State and Regional Commercial Prioritization Framework
FIGURE 139: Report Scope and Disclaimer Framework